| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Departments of Microbiology [M. W. S., Z. N. Y., G. K. G., V. S. C., R. E. B., M. G. K.] and Pathology [C. A. L., N. F.], School of Medicine, and Washington National Primate Research Center [N. Y. S., M. G. K.], University of Washington, Seattle, Washington 98195; Barcelona Clinic Liver Cancer Group, Liver Unit, Digestive Disease Institute, Hospital Clinic i Provincial, Villaroel 170, 08036 Barcelona, Catalonia, Spain [L. B., J. B.]; and Illumigen Biosciences Inc., Seattle, Washington 98119 [G. B. R.]
Hepatocellular carcinoma (HCC) is a common primary cancer associated frequently with hepatitis C virus (HCV). To gain insight into the molecular mechanisms of hepatocarcinogenesis, and to identify potential HCC markers, we performed cDNA microarray analysis on surgical liver samples from 20 HCV-infected patients. RNA from individual tumors was compared with RNA isolated from adjacent nontumor tissue that was cirrhotic in all of the cases. Gene expression changes related to cirrhosis were filtered out using experiments in which pooled RNA from HCV-infected cirrhotic liver without tumors was compared with pooled RNA from normal liver. Expression of
13,600 genes was analyzed using the advanced analysis tools of the Rosetta Resolver System. This analysis revealed a set of 50 potential HCC marker genes, which were up-regulated in the majority of the tumors analyzed, much more widely than common clinical markers such as cell proliferation-related genes. This HCC marker set contained several cancer-related genes, including serine/threonine kinase 15 (STK15), which has been implicated in chromosome segregation abnormalities but which has not been linked previously with liver cancer. In addition, a set of genes encoding secreted or plasma proteins was identified, including plasma glutamate carboxypeptidase (PGCP) and two secreted phospholipases A2 (PLA2G13 and PLA2G7). These genes may provide potential HCC serological markers because of their strong up-regulation in more than half of the tumors analyzed. Thus, high throughput methods coupled with high-order statistical analyses may result in the development of new diagnostic tools for liver malignancies.
This article has been cited by other articles:
![]() |
R. W. C. Pang, J. W. Joh, P. J. Johnson, M. Monden, T. M. Pawlik, and R. T. P. Poon Biology of Hepatocellular Carcinoma Ann. Surg. Oncol., April 1, 2008; 15(4): 962 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Budhu, Y Chen, J.W. Kim, M Forgues, K Valerie, C.C. Harris, and X.W. Wang Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins Carcinogenesis, July 1, 2007; 28(7): 1552 - 1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Luo, L. Siconolfi-Baez, P. Annamaneni, M. T. Bielawski, P. M. Novikoff, and R. H. Angeletti Altered protein expression at early-stage rat hepatic neoplasia Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1272 - G1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ito, S.-i. Funahashi, N. Yamauchi, J. Shibahara, Y. Midorikawa, S. Kawai, Y. Kinoshita, A. Watanabe, Y. Hippo, T. Ohtomo, et al. Identification of ROBO1 as a Novel Hepatocellular Carcinoma Antigen and a Potential Therapeutic and Diagnostic Target. Clin. Cancer Res., June 1, 2006; 12(11): 3257 - 3264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sato, M. Fukasawa, Y. Yamakawa, T. Natsume, T. Suzuki, I. Shoji, H. Aizaki, T. Miyamura, and M. Nishijima Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem., May 1, 2006; 139(5): 921 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Weng, H. Dai, Y. Zhan, Y. He, S. B. Stepaniants, and D. E. Bassett Rosetta error model for gene expression analysis Bioinformatics, May 1, 2006; 22(9): 1111 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Jolly, K. M. Goldstein, T. Wei, H. Gao, P. Chen, S. Huang, J.-M. Colet, T. P. Ryan, C. E. Thomas, and S. T. Estrem Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants Physiol Genomics, August 11, 2005; 22(3): 346 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. R. Yu, J.-M. Hsu, Y.-C. G. Lee, A.-P. Tsou, C.-K. Chou, and C.-Y. F. Huang Phosphorylation and Stabilization of HURP by Aurora-A: Implication of HURP as a Transforming Target of Aurora-A Mol. Cell. Biol., July 15, 2005; 25(14): 5789 - 5800. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Jacobs, D. L. Diamond, E. Y. Chan, M. A. Gritsenko, W. Qian, M. Stastna, T. Baas, D. G. Camp II, R. L. Carithers Jr., R. D. Smith, et al. Proteome Analysis of Liver Cells Expressing a Full-Length Hepatitis C Virus (HCV) Replicon and Biopsy Specimens of Posttransplantation Liver from HCV-Infected Patients J. Virol., June 15, 2005; 79(12): 7558 - 7569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Baskin, A. Garcia-Sastre, T. M. Tumpey, H. Bielefeldt-Ohmann, V. S. Carter, E. Nistal-Villan, and M. G. Katze Integration of Clinical Data, Pathology, and cDNA Microarrays in Influenza Virus-Infected Pigtailed Macaques (Macaca nemestrina) J. Virol., October 1, 2004; 78(19): 10420 - 10432. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hippo, K. Watanabe, A. Watanabe, Y. Midorikawa, S. Yamamoto, S. Ihara, S. Tokita, H. Iwanari, Y. Ito, K. Nakano, et al. Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma Cancer Res., April 1, 2004; 64(7): 2418 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cashion, C. J. Driscoll, and O. Sabek Emerging Genetic Technologies in Clinical and Research Settings Biol Res Nurs, January 1, 2004; 5(3): 159 - 167. [Abstract] [PDF] |
||||
![]() |
W. Kim, S. Oe Lim, J.-S. Kim, Y. H. Ryu, J.-Y. Byeon, H.-J. Kim, Y.-I. Kim, J. S. Heo, Y. M. Park, and G. Jung Comparison of Proteome between Hepatitis B Virus- and Hepatitis C Virus-Associated Hepatocellular Carcinoma Clin. Cancer Res., November 15, 2003; 9(15): 5493 - 5500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |